• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚甲蓝改善神经炎症性阿尔茨海默病小鼠模型中的脑线粒体ABAD功能并降低β淀粉样蛋白水平

Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model.

作者信息

Zakaria Aya, Hamdi Nabila, Abdel-Kader Reham Mahmoud

机构信息

Department of Pharmacology & Toxicology, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt.

出版信息

Mol Neurobiol. 2016 Mar;53(2):1220-1228. doi: 10.1007/s12035-014-9088-8. Epub 2015 Jan 20.

DOI:10.1007/s12035-014-9088-8
PMID:25601181
Abstract

Methylene blue (MB) phase II clinical trials reported improvements in cognitive functions of Alzheimer's disease (AD) patients. Regarding MB mechanism of action, its antioxidant and mitochondrial protective effects have been previously described. In relation to AD, it has been recently reported that MB reduced amyloid beta (Aβ) levels in AD models. The mitochondrial enzyme amyloid-binding alcohol dehydrogenase (ABAD) has been shown to bind Aβ inducing mitochondrial dysfunction, providing a direct relation between Aβ toxicity and mitochondrial dysfunction occurring in AD. Since it has been reported that inhibiting ABAD protects mitochondrial functions and prevents Aβ-induced toxicity, the aim of the current study was to investigate if the protective effects of MB could be associated with an effect on ABAD levels and functions. The current study shows that MB is able to enhance cell viability, reduce both reactive oxygen species levels and importantly Aβ oligomers in a lipopolysaccharide (LPS) mouse model. Interestingly, ABAD levels were increased in the brains of the LPS mouse model and MB treatment was able to reduce its levels. Given that regulation of the estradiol level is a well-established function of ABAD, brain estradiol level was compared in LPS mouse model and in MB-treated mice. The results of the current study show that MB treatment is able to improve significantly the LPS-induced decrease of estradiol levels in mice brains, indicating its ability to modulate both levels and function of ABAD. These results give a new insight to possible mechanisms of MB in AD.

摘要

亚甲蓝(MB)的II期临床试验报告称,阿尔茨海默病(AD)患者的认知功能有所改善。关于MB的作用机制,其抗氧化和线粒体保护作用此前已有描述。关于AD,最近有报道称MB可降低AD模型中的淀粉样β蛋白(Aβ)水平。线粒体酶淀粉样蛋白结合醇脱氢酶(ABAD)已被证明可结合Aβ,诱导线粒体功能障碍,这为AD中发生的Aβ毒性与线粒体功能障碍之间提供了直接联系。由于有报道称抑制ABAD可保护线粒体功能并预防Aβ诱导的毒性,因此本研究的目的是调查MB的保护作用是否与对ABAD水平和功能的影响有关。本研究表明,在脂多糖(LPS)小鼠模型中,MB能够提高细胞活力,降低活性氧水平,重要的是还能降低Aβ寡聚体水平。有趣的是,LPS小鼠模型大脑中的ABAD水平升高,而MB治疗能够降低其水平。鉴于调节雌二醇水平是ABAD的一项既定功能,对LPS小鼠模型和接受MB治疗的小鼠的大脑雌二醇水平进行了比较。本研究结果表明,MB治疗能够显著改善LPS诱导的小鼠大脑中雌二醇水平的降低,表明其具有调节ABAD水平和功能的能力。这些结果为MB在AD中的可能作用机制提供了新的见解。

相似文献

1
Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model.亚甲蓝改善神经炎症性阿尔茨海默病小鼠模型中的脑线粒体ABAD功能并降低β淀粉样蛋白水平
Mol Neurobiol. 2016 Mar;53(2):1220-1228. doi: 10.1007/s12035-014-9088-8. Epub 2015 Jan 20.
2
Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol.抑制线粒体酶 ABAD 可恢复淀粉样蛋白-β介导的雌二醇失调。
PLoS One. 2011;6(12):e28887. doi: 10.1371/journal.pone.0028887. Epub 2011 Dec 12.
3
Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.抑制淀粉样蛋白-β(Abeta)肽结合型醇脱氢酶- Abeta 相互作用可减少阿尔茨海默病小鼠模型中的 Abeta 积累并改善线粒体功能。
J Neurosci. 2011 Feb 9;31(6):2313-20. doi: 10.1523/JNEUROSCI.4717-10.2011.
4
ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.ABAD将阿尔茨海默病中的β淀粉样蛋白与线粒体毒性直接联系起来。
Science. 2004 Apr 16;304(5669):448-52. doi: 10.1126/science.1091230.
5
ABAD/17β-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP/PS1 mice.ABAD/17β-HSD10 的减少有助于石杉碱甲对 APP/PS1 小鼠大脑线粒体功能的保护作用。
Neurobiol Aging. 2019 Sep;81:77-87. doi: 10.1016/j.neurobiolaging.2019.05.016. Epub 2019 May 28.
6
[Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease].[线粒体酶ABAD及其在阿尔茨海默病发生发展与治疗中的作用]
Ceska Slov Farm. 2012 Aug;61(4):144-9.
7
Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.淀粉样蛋白结合型醇脱氢酶(ABAD)抑制剂治疗阿尔茨海默病。
J Med Chem. 2019 May 9;62(9):4252-4264. doi: 10.1021/acs.jmedchem.8b01530. Epub 2018 Nov 30.
8
ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.ABAD通过线粒体功能障碍增强β-淀粉样蛋白诱导的细胞应激。
FASEB J. 2005 Apr;19(6):597-8. doi: 10.1096/fj.04-2582fje. Epub 2005 Jan 21.
9
Functionalized Allopurinols Targeting Amyloid-Binding Alcohol Dehydrogenase Rescue Aβ-Induced Mitochondrial Dysfunction.靶向淀粉样蛋白结合型醇脱氢酶的功能化别嘌醇可挽救 Aβ 诱导的线粒体功能障碍。
ACS Chem Neurosci. 2022 Jul 20;13(14):2176-2190. doi: 10.1021/acschemneuro.2c00246. Epub 2022 Jul 8.
10
Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD).线粒体功能障碍与阿尔茨海默病:淀粉样β肽醇脱氢酶(ABAD)的作用
Int J Exp Pathol. 2005 Jun;86(3):161-71. doi: 10.1111/j.0959-9673.2005.00427.x.

引用本文的文献

1
Mitochondrial Damage and Autophagy Dysregulation in Alzheimer's Disease: Mechanisms and Therapeutic Opportunities.阿尔茨海默病中的线粒体损伤与自噬失调:机制与治疗机遇
Neurochem Res. 2025 Jul 28;50(4):251. doi: 10.1007/s11064-025-04490-z.
2
High-Throughput Screening of Potent Drug-like Molecules Targeting 17β-HSD10 for the Treatment of Alzheimer's Disease and Cancer.针对17β-羟类固醇脱氢酶10(17β-HSD10)的强效类药物分子的高通量筛选用于治疗阿尔茨海默病和癌症
ACS Chem Biol. 2025 Jul 18;20(7):1544-1559. doi: 10.1021/acschembio.5c00110. Epub 2025 Jun 18.
3
Exosome-mediated dual drug delivery of curcumin and methylene blue for enhanced cognitive function and mechanistic elucidation in Alzheimer's disease therapy.

本文引用的文献

1
Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice.亚甲蓝调节β-分泌酶,逆转脑淀粉样变性,改善转基因小鼠的认知功能。
J Biol Chem. 2014 Oct 31;289(44):30303-30317. doi: 10.1074/jbc.M114.568212. Epub 2014 Aug 25.
2
Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy.亚甲蓝不能逆转tau蛋白病的rTg4510小鼠模型中现有的神经原纤维缠结病理。
Neurosci Lett. 2014 Mar 6;562:63-8. doi: 10.1016/j.neulet.2014.01.013. Epub 2014 Jan 21.
3
Tau-aggregation inhibitor therapy for Alzheimer's disease.
外泌体介导的姜黄素和亚甲蓝双重药物递送用于增强阿尔茨海默病治疗中的认知功能及机制阐释
Front Cell Dev Biol. 2025 Mar 24;13:1562565. doi: 10.3389/fcell.2025.1562565. eCollection 2025.
4
Origanum majorana L. protects against neuroinflammation-mediated cognitive impairment: a phyto-pharmacological study.马郁兰(Origanum majorana L.)可预防神经炎症介导的认知障碍:植物药理学研究。
BMC Complement Med Ther. 2023 May 20;23(1):165. doi: 10.1186/s12906-023-03994-x.
5
Aurantiamide suppresses the activation of NLRP3 inflammasome to improve the cognitive function and central inflammation in mice with Alzheimer's disease.橙皮酰胺通过抑制 NLRP3 炎性小体的激活改善阿尔茨海默病模型小鼠的认知功能和中枢炎症
CNS Neurosci Ther. 2023 Apr;29(4):1075-1085. doi: 10.1111/cns.14082. Epub 2023 Jan 10.
6
Methylene Blue Delivery Mediated by Focused Ultrasound-Induced Blood-Brain Barrier Disruption Reduces Neural Damage and Amyloid-Beta Plaques by AQP-4 Upregulation.聚焦超声诱导血脑屏障破坏介导的亚甲蓝递送通过上调水通道蛋白-4减少神经损伤和β淀粉样蛋白斑块
Biomedicines. 2022 Dec 8;10(12):3191. doi: 10.3390/biomedicines10123191.
7
The Role of a Pathological Interaction between β-amyloid and Mitochondria in the Occurrence and Development of Alzheimer's Disease.β-淀粉样蛋白与线粒体之间的病理相互作用在阿尔茨海默病发生发展中的作用
Acta Naturae. 2022 Jul-Sep;14(3):19-34. doi: 10.32607/actanaturae.11723.
8
Epigenetic regulation of aging: implications for interventions of aging and diseases.衰老的表观遗传学调控:干预衰老和疾病的意义。
Signal Transduct Target Ther. 2022 Nov 7;7(1):374. doi: 10.1038/s41392-022-01211-8.
9
Mitochondria targeting drugs for neurodegenerative diseases-Design, mechanism and application.用于神经退行性疾病的线粒体靶向药物——设计、作用机制及应用
Acta Pharm Sin B. 2022 Jun;12(6):2778-2789. doi: 10.1016/j.apsb.2022.03.001. Epub 2022 Mar 10.
10
Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization.衰老导向的 FDA 批准药物再利用:一种建议的流程和优先级。
Aging Cell. 2022 Apr;21(4):e13596. doi: 10.1111/acel.13596. Epub 2022 Mar 27.
tau 聚集抑制剂治疗阿尔茨海默病。
Biochem Pharmacol. 2014 Apr 15;88(4):529-39. doi: 10.1016/j.bcp.2013.12.008. Epub 2013 Dec 19.
4
Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies.用于阿尔茨海默病及其他tau蛋白病的亚甲蓝纳米颗粒的制备与表征
Curr Drug Deliv. 2014;11(4):541-50. doi: 10.2174/1567201810666131113102037.
5
Therapeutic and preventive effects of methylene blue on Alzheimer's disease pathology in a transgenic mouse model.亚甲蓝对转基因小鼠模型阿尔茨海默病病理的治疗和预防作用。
Neuropharmacology. 2014 Jan;76 Pt A:68-79. doi: 10.1016/j.neuropharm.2013.06.033. Epub 2013 Jul 23.
6
Mechanistic basis of phenothiazine-driven inhibition of Tau aggregation.吩噻嗪驱动的 Tau 蛋白聚集抑制作用的机制基础。
Angew Chem Int Ed Engl. 2013 Mar 18;52(12):3511-5. doi: 10.1002/anie.201208290. Epub 2013 Feb 11.
7
Different fates of Alzheimer's disease amyloid-β fibrils remodeled by biocompatible small molecules.不同命运的阿尔茨海默病淀粉样-β纤维由生物相容性小分子重塑。
Biomacromolecules. 2013 Jan 14;14(1):264-74. doi: 10.1021/bm3016994. Epub 2012 Dec 3.
8
Neuroprotective actions of methylene blue and its derivatives.亚甲蓝及其衍生物的神经保护作用。
PLoS One. 2012;7(10):e48279. doi: 10.1371/journal.pone.0048279. Epub 2012 Oct 31.
9
Methylene blue as a cerebral metabolic and hemodynamic enhancer.亚甲蓝作为一种脑代谢和血流动力学增强剂。
PLoS One. 2012;7(10):e46585. doi: 10.1371/journal.pone.0046585. Epub 2012 Oct 9.
10
Amyloid-β peptide binds to cytochrome C oxidase subunit 1.β淀粉样肽结合细胞色素 C 氧化酶亚基 1。
PLoS One. 2012;7(8):e42344. doi: 10.1371/journal.pone.0042344. Epub 2012 Aug 21.